Senior insider sale
See Remarks at MEREO BIOPHARMA GROUP PLC — senior position signals high conviction
$805.6K
181.21K shares
What this filing means
HUGHES-WILSON ALEXANDRA plans to sell 181.21K shares of MEREO BIOPHARMA GROUP PLC valued at approximately $805.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/12/2024ACC: 0000950170-24-105906
Officer· See Remarks
Since Feb 2026
181.21K
Shares to sell
$805.6K
Approx. market value
164.04K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Same Day Cashless Exercise and Sale
Equity Compensation
9/12/2024
164.04KTotal acquired164.04K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/12/2024 | Same Day Cashless Exercise and Sale Equity Compensation | 164.04K | — |
| Total | 164.04K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
22.97K
Market value
$77.9K
6/26/2024
—Completed
Units to sell
10.13K
Market value
$37.4K
6/25/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
148.11K
Market value
$690.2K
9/12/2024
Total
Units
181.21K
Value
$805.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/26/2024 | 22.97K | $77.9K | — | Completed |
6/25/2024 | 10.13K | $37.4K | — | Completed |
| Planned — Approximate Date | ||||
9/12/2024 | 148.11K | $690.2K | NASDAQ | Planned |
| Total | 181.21K | $805.6K | ||